These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2155486)

  • 1. The impact of pretransplant herpesvirus serology on acute and chronic graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation.
    Boström L; Ringdén O; Gratama JW; Jacobsen N; Zwaan F; Nilsson B
    Transplant Proc; 1990 Feb; 22(1):206-7. PubMed ID: 2155486
    [No Abstract]   [Full Text] [Related]  

  • 2. A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation.
    Boström L; Ringdén O; Gratama JW; Jacobsen N; Prentice HG; Zwaan FE; Nilsson B
    Bone Marrow Transplant; 1990 May; 5(5):321-6. PubMed ID: 2190659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant herpes virus serology and chronic graft-versus-host disease.
    Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
    Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesvirus infections in the immunocompromised patient.
    Skinhøj P
    Scand J Infect Dis Suppl; 1985; 47():121-7. PubMed ID: 3006227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant herpesvirus serology and acute graft-versus-host disease.
    Boström L; Ringdén O; Sundberg B; Linde A; Tollemar J; Nilsson B
    Transplantation; 1988 Oct; 46(4):548-52. PubMed ID: 2845612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes virus immunity and acute graft-versus-host disease.
    Gratama JW; Weiland HT; Hekker AC; Weijers TF; The TH; Stijnen T; Zwaan FE; Vossen JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2680-2. PubMed ID: 2856285
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
    Robin M; Guardiola P; Dombret H; Baruchel A; Esperou H; Ribaud P; Devergie A; Gluckman E; Socié G
    Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
    Ruutu T; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1997 Apr; 19(8):759-64. PubMed ID: 9134165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
    Speiser DE; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1997 Jun; 19(12):1197-203. PubMed ID: 9208113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
    Clerici M; Villa ML; Clerici E
    Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease.
    Gratama JW; Fibbe WE; Naipal AM; Slats J; Stijnen T; D'Amaro J; Bolhuis RL; The TH; Janssen J
    Bone Marrow Transplant; 1986 Dec; 1(2):141-6. PubMed ID: 2844332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes-virus immunity and acute graft-versus-host disease.
    Gratama JW; Zwaan FE; Stijnen T; Weijers TF; Weiland HT; D'Amaro J; Hekker AC; The TH; de Gast GC; Vossen JM
    Lancet; 1987 Feb; 1(8531):471-4. PubMed ID: 2881039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How should corticosteroids be used in the treatment of acute GVHD? EBMT Chronic Leukemia Working Party. European Group for Blood and Marrow Transplantation.
    Ruutu T; Hermans J; van Biezen A; Niederwieser D; Gratwohl A; Apperley JF
    Bone Marrow Transplant; 1998 Sep; 22(6):614-5. PubMed ID: 9758357
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
    Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
    [No Abstract]   [Full Text] [Related]  

  • 18. The graft-versus-leukaemia effect after allogeneic bone-marrow transplantation: assessment through competing risks approaches.
    Katsahian S; Porcher R; Mary JY; Chevret S
    Stat Med; 2004 Dec; 23(24):3851-63. PubMed ID: 15580602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
    Rowe JM
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.